Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 1
1975 1
1977 2
1978 1
1979 1
1980 1
1981 1
1982 2
1983 6
1984 1
1985 1
1986 5
1987 6
1988 8
1989 11
1990 11
1991 21
1992 20
1993 21
1994 20
1995 31
1996 41
1997 38
1998 60
1999 77
2000 107
2001 104
2002 108
2003 129
2004 163
2005 188
2006 226
2007 284
2008 325
2009 366
2010 428
2011 496
2012 563
2013 586
2014 636
2015 702
2016 638
2017 717
2018 706
2019 718
2020 785
2021 836
2022 743
2023 693
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10,362 results

Results by year

Filters applied: . Clear all
Page 1
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up.
Powles T, Park SH, Caserta C, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Sternberg CN, Bellmunt J, Aragon-Ching JB, Wang J, Huang B, Laliberte RJ, di Pietro A, Grivas P. Powles T, et al. Among authors: park sh. J Clin Oncol. 2023 Jul 1;41(19):3486-3492. doi: 10.1200/JCO.22.01792. Epub 2023 Apr 18. J Clin Oncol. 2023. PMID: 37071838 Free PMC article. Clinical Trial.
Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial.
Grivas P, Park SH, Voog E, Caserta C, Gurney H, Bellmunt J, Kalofonos H, Ullén A, Loriot Y, Sridhar SS, Yamamoto Y, Petrylak DP, Sternberg CN, Gupta S, Huang B, Costa N, Laliberte RJ, di Pietro A, Valderrama BP, Powles T. Grivas P, et al. Among authors: park sh. Eur Urol. 2023 Jul;84(1):95-108. doi: 10.1016/j.eururo.2023.03.030. Epub 2023 Apr 28. Eur Urol. 2023. PMID: 37121850 Free article. Clinical Trial.
T-large granular lymphocytic leukemia.
Park SH, Lee YJ, Kim Y, Kim HK, Lim JH, Jo JC. Park SH, et al. Blood Res. 2023 Apr 30;58(S1):S52-S57. doi: 10.5045/br.2023.2023037. Epub 2023 Apr 7. Blood Res. 2023. PMID: 37026382 Free PMC article. Review.
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.
Han JK, Hwang D, Yang S, Park SH, Kang J, Yang HM, Park KW, Kang HJ, Koo BK, Hur SH, Kim W, Kim SY, Park SH, Han SH, Kim SH, Shin S, Kim YH, Park K, Lee N, Lee SJ, Kim JW, Kim HS. Han JK, et al. Among authors: park sh. Circulation. 2023 May 2;147(18):1358-1368. doi: 10.1161/CIRCULATIONAHA.123.064264. Epub 2023 Mar 5. Circulation. 2023. PMID: 36871230 Clinical Trial.
Plasmacytoid dendritic cell neoplasms.
Lee YJ, Kim Y, Park SH, Jo JC. Lee YJ, et al. Among authors: park sh. Blood Res. 2023 Apr 30;58(S1):90-95. doi: 10.5045/br.2023.2023052. Blood Res. 2023. PMID: 37105563 Free PMC article. Review.
Brain Tumor Classification by Methylation Profile.
Park JW, Lee K, Kim EE, Kim SI, Park SH. Park JW, et al. Among authors: park sh. J Korean Med Sci. 2023 Nov 6;38(43):e356. doi: 10.3346/jkms.2023.38.e356. J Korean Med Sci. 2023. PMID: 37935168 Free PMC article. Review.
Chromatinization modulates topoisomerase II processivity.
Lee J, Wu M, Inman JT, Singh G, Park SH, Lee JH, Fulbright RM, Hong Y, Jeong J, Berger JM, Wang MD. Lee J, et al. Among authors: park sh. Nat Commun. 2023 Oct 27;14(1):6844. doi: 10.1038/s41467-023-42600-z. Nat Commun. 2023. PMID: 37891161 Free PMC article.
Chromatinization Modulates Topoisomerase II Processivity.
Lee J, Wu M, Inman JT, Singh G, Park SH, Lee JH, Fulbright RM, Hong Y, Jeong J, Berger JM, Wang MD. Lee J, et al. Among authors: park sh. bioRxiv. 2023 Oct 4:2023.10.03.560726. doi: 10.1101/2023.10.03.560726. Preprint. bioRxiv. 2023. PMID: 37873421 Free PMC article. Updated.
10,362 results
You have reached the last available page of results. Please see the User Guide for more information.